Rodgers Richard J
SEC-identified person · CIK 1313397 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Novavax INC nvax | Director | filed 2022–2026 |
| Ardelyx, INC. ARDX | Director | filed 2014–2026 |
| Rexahn Pharmaceuticals, INC. RXHN.OB | Director · Interim CEO and President | filed 2014–2026 |
| Sagimet Biosciences Inc. SGMT | Director | filed 2023–2023 |
| Tesaro, Inc. TSRO | Executive VP & CFO | filed 2012–2013 |
| New Abraxis, Inc. ABII | Senior Vice President and CFO | filed 2009–2009 |
| MGI Pharma INC MOGN | VP & Controller | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.